Trade Summary

2 months ago, Reynolds Cameron John, serving as Pres, CEO at Volitionrx Ltd (VNRX), purchased 110,000 shares at $0.51 per share, for a total transaction value of $56,100.00. Following this transaction, Reynolds Cameron John now holds 3,576,641 shares of VNRX.

This purchase represents a 3.00% increase in Reynolds Cameron John's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, October 14, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, October 15, 2025, 1 day after the trade was made.

Volitionrx Ltd operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.